Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ACUTE

initial Gram stain suggestive of gonorrhea: nonpregnant

Back
1st line – 

cephalosporin monotherapy or gentamicin plus azithromycin

For symptomatic people with initial Gram stain showing gram-negative intracellular diplococci, presumptive treatment for both gonococcal and nongonococcal urethritis should be given.[1]​​[32][42][43]

The Centers for Disease Control and Prevention recommends a single dose of intramuscular ceftriaxone for uncomplicated gonorrhea.[1]

If ceftriaxone is not available, oral cefixime is a suitable alternative agent.[1] Consult specialist for guidance on other alternative injectable cephalosporin options.  

In patients who have a cephalosporin allergy, intramuscular gentamicin in a single dose plus a high dose of azithromycin may be considered; however, gastrointestinal adverse effects may limit the use of these regimens.[1] 

Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]

All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1][44] [ Cochrane Clinical Answers logo ] ​ The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47][Figure caption and citation for the preceding image starts]: Gram stain of urethral exudate showing gram-negative diplococci and polymorphonuclear leukocytesAdapted from Public Health Image Library, CDC; Jacobs N, 1974 [Citation ends].com.bmj.content.model.Caption@1a8d86f8

Primary options

ceftriaxone: body weight <150 kg: 500 mg intramuscularly as a single dose; body weight ≥150 kg: 1000 mg intramuscularly as a single dose

Secondary options

cefixime: 800 mg orally as a single dose

Tertiary options

gentamicin: 240 mg intramuscularly as a single dose

and

azithromycin: 2 g orally as a single dose

Back
Consider – 

doxycycline

Treatment recommended for SOME patients in selected patient group

If chlamydial infection has not been excluded, patients should also receive oral doxycycline for 7 days (unless they are receiving the gentamicin plus azithromycin regimen).[1]

Primary options

doxycycline: 100 mg orally twice daily for 7 days

initial Gram stain suggestive of gonorrhea: pregnant

Back
1st line – 

cephalosporin monotherapy

For symptomatic people with initial Gram stain showing gram-negative intracellular diplococci, presumptive treatment for both gonococcal and nongonococcal urethritis should be given.[1][32][43]​​

Pregnant women should be treated with ceftriaxone monotherapy first-line.[1]

Consultation with an infectious disease specialist is recommended if the patient has a cephalosporin allergy or there are any other considerations that preclude treatment with these agents.

Pregnant women should be retested to ensure cure, preferably with a nucleic acid amplification test such as ligase chain reaction or polymerase chain reaction of urethral discharge and/or urine sediment. Chlamydia test of cure is recommended 4 weeks after treatment, with a retest at 3 months. Retest for gonorrhea is recommended at 3 months.[1]

Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]

All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1][44] [ Cochrane Clinical Answers logo ] ​ The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47][Figure caption and citation for the preceding image starts]: Gram stain of urethral exudate showing gram-negative diplococci and polymorphonuclear leukocytesAdapted from Public Health Image Library, CDC; Jacobs N, 1974 [Citation ends].com.bmj.content.model.Caption@31aead75

Primary options

ceftriaxone: 500 mg intramuscularly as a single dose

Back
Consider – 

azithromycin

Treatment recommended for SOME patients in selected patient group

If chlamydial infection has not been excluded, a single dose of azithromycin is also recommended in pregnant women.[1]

Primary options

azithromycin: 1 g orally as a single dose

initial Gram stain not suggestive of gonorrhea: nonpregnant

Back
1st line – 

doxycycline or azithromycin

Patients are initially treated for nongonococcal urethritis (NGU) alone with all symptomatic people having NAAT testing for Chlamydia trachomatis, Mycoplasma genitalium, and Neisseria gonorrhoea, even if initial Gram stain tests are negative for evidence of gonococci.[27]​​

Presumptive treatment with doxycycline is recommended, as this drug is highly effective for C trachomatis and has some activity against M genitalium.[1]

Azithromycin should be considered as a secondary treatment option due to increasing reports of treatment failure and macrolide antimicrobial resistance with M genitalium.[29]​​[48]​ A multi-day azithromycin dosing regimen may protect against inducingM genitalium resistance.[1]

Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]

All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1][44] [ Cochrane Clinical Answers logo ] ​ The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]

If subsequent nucleic acid amplification testing (NAAT) and/or culture testing results are available, the choice of antibiotic for definitive antibiotic therapy is based on the local epidemiology of specific infections and antimicrobial sensitivity patterns. If a NAAT is positive for gonorrhea, a culture should be performed before antigonococcal treatment is added.[29]​ Consultation with an infectious disease specialist is recommended.

Primary options

doxycycline: 100 mg orally twice daily for 7 days

Secondary options

azithromycin: 1 g orally as a single dose; or 500 mg orally as a single dose, followed by 250 mg once daily for 4 days

initial Gram stain not suggestive of gonorrhea: pregnant

Back
1st line – 

azithromycin or amoxicillin

Pregnant women should be treated with azithromycin first-line.[1]

Amoxicillin is an alternative treatment if chlamydial infection is detected.[1]

Doxycycline and flouroquinolones are not recommended in pregnancy.

Consultation with an infectious disease specialist is recommended if the patient has any considerations that preclude treatment with these regimens.

Pregnant women should be retested to ensure cure, preferably with a nucleic acid amplification test such as ligase chain reaction or polymerase chain reaction of urethral discharge and/or urine sediment. Chlamydia test of cure is recommended 4 weeks after treatment, with a retest at 3 months. Retest for gonorrhea is recommended at 3 months.[1]

Urethritis may facilitate HIV transmission. Treatment is the same in people with HIV as in people without HIV.[1]

All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1][44] [ Cochrane Clinical Answers logo ] ​ The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]

If subsequent nucleic acid amplification testing (NAAT) and/or culture testing results are available, the choice of antibiotic for definitive antibiotic therapy is based on the local epidemiology of specific infections and antimicrobial sensitivity patterns. If a NAAT is positive for gonorrhea, a culture should be performed before antigonococcal treatment is added.[29]​ Consultation with an infectious disease specialist is recommended.

Primary options

azithromycin: 1 g orally as a single dose; or 500 mg orally as a single dose, followed by 250 mg once daily for 4 days

Secondary options

amoxicillin: 500 mg orally three times daily for 7 days

ONGOING

recurrent or resistant urethritis

Back
1st line – 

repeat of initial treatment

If the patient did not complete initial treatment or was re-exposed by an untreated partner, he/she may be retreated with the same regimen as used initially.

Back
1st line – 

alternative antibiotic therapy ± referral

Treatment failure should be considered in the following patients: patients whose symptoms do not resolve in 3-5 days after appropriate treatment and who report no sexual contact during the post-treatment period; patients with a positive test of cure (i.e., positive culture >72 hours or nucleic acid amplification test >7 days after receiving recommended treatment) and who report no sexual contact during the post-treatment period.[1]

In cases of suspected cephalosporin treatment failure, clinicians should obtain relevant clinical specimens for culture and consult an infectious disease specialist.[1]

For refractory cases, rare causes such as herpetic urethritis should be ruled out.

Back
1st line – 

alternative antibiotic therapy ± referral

Treatment failure should be considered in the following patients: patients whose symptoms do not resolve in 3-5 days after appropriate treatment and who report no sexual contact during the post-treatment period; patients with a positive test of cure (i.e., positive culture >72 hours or nucleic acid amplification test >7 days after receiving recommended treatment) and who report no sexual contact during the post-treatment period.[1]

In areas where Trichomonas vaginalis is prevalent, men who have sex with women and have persistent or recurrent urethritis should be presumptively treated with metronidazole or tinidazole.[1]

If T vaginalis is unlikely, and Mycoplasma genitalium is detected on testing, resistance testing directs appropriate therapy.[1] If M genitalium is macrolide resistant or resistance testing for M genitalium is unavailable, patients should be presumptively treated with doxycycline to decrease bacterial load, followed by moxifloxacin to clear the infection.[1] Antibiotic regimens may vary according to local protocols; consult local guidance. 

Systemic fluoroquinolone antibiotics, such as moxifloxacin, may cause serious, disabling, and potentially long-lasting or irreversible adverse events. This includes, but is not limited to, tendinopathy/tendon rupture; peripheral neuropathy; arthropathy/arthralgia; aortic aneurysm and dissection; heart valve regurgitation; dysglycemia; and central nervous system effects including seizures, depression, psychosis, and suicidal thoughts and behavior.[49]​ Prescribing restrictions apply to the use of fluoroquinolones, and these restrictions may vary between countries. In general, fluoroquinolones should be restricted for use in serious, life-threatening bacterial infections only. Some regulatory agencies may also recommend that they must only be used in situations where other antibiotics, that are commonly recommended for the infection, are inappropriate (e.g., resistance, contraindications, treatment failure, unavailability). Consult your local guidelines and drug formulary for more information on suitability, contraindications, and precautions.

Patients with persistent or recurrent NGU after presumptive treatment for M genitalium or T vaginalis should be referred to a specialist for treatment.[1]

Treatment failures should prompt consultation with an infectious disease specialist and be reported to the Centers for Disease Control and Prevention through the local or state health department within 24 hours of diagnosis.[1]

For refractory cases, rare causes such as herpetic urethritis should be ruled out.

All sex partners within the last 60 days should be referred for evaluation and possible treatment.[1][44] [ Cochrane Clinical Answers logo ] ​ The management of a patient’s sex partners is an important consideration to prevent reinfection and further transmission.[47]

Primary options

Trichomonas vaginalis

metronidazole: 2 g orally as a single dose

OR

Trichomonas vaginalis

tinidazole: 2 g orally as a single dose

OR

Mycoplasma genitalium, resistance testing available

doxycycline: 100 mg orally twice daily for 7 days

and

azithromycin: 1 g orally as a single dose, followed by 500 mg once daily for 3 days

OR

Mycoplasma genitalium, resistance testing unavailable or macrolide resistant

doxycycline: 100 mg orally twice daily for 7 days

and

moxifloxacin: 400 mg orally once daily for 7 days

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer